Document is current

Any future updates will be listed below

Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

Crossref DOI link: https://doi.org/10.1186/S13063-019-3940-0

Published Online: 2019-12-13

Published Print: 2019-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

About CrossMark